Abstract:Background
In the era of COVID-19, utilization of telemedicine has dramatically increased. In addition to reduced travel times, patient expenses, and work or school days missed, telemedicine allows clinicians to provide continued care while minimizing face-to-face interactions, maintaining social distancing, and limiting potential COVID-19 exposures. Clinical Immunology and Allergy (CIA), like many specialties, has adapted to incorporate telemedicine into practice. Previous studies have demonst… Show more
“…Limited face-to-face consultations and as much as the use of telemedicine is currently seen as the major issues in the allergy practice. Face-to-face examination and treatment should be preferred only in vital situations [33]. The treatment of allergic patients should not be interrupted, or dose reduction should not be made.…”
Over the recent time period, pediatric allergy clinics across the world have markedly changed their practice because of the COVID-19 pandemic. Nowadays, clinics are not inclined to accept a patient demanding a new procedure / therapeutic modality during pandemic. All allergic diseases require continuous management and treatment, and their socioeconomic burden has been increasing worldwide. In this chapter, the aim is to focus on allergic diseases management during pandemic. During this time, patient follow-up, patient management, and diagnostic tests are real challenges. Limited face-to-face consultations and as much as use of telemedicine are currently seen as the major issues in the allergy practice. Face-to-face examination and treatment should be preferred only in vital situations. During COVID-19 pandemic, patient education, which is the most important step in the treatment of allergic diseases, has started to be done online. The prevailing opinion in the allergy community is that the treatment should not be interrupted, or dose reduction should not be made. According to the guidelines, it is appropriately recommended to carefully calculate the profit and loss of the treatment on a case-by-case basis.
“…Limited face-to-face consultations and as much as the use of telemedicine is currently seen as the major issues in the allergy practice. Face-to-face examination and treatment should be preferred only in vital situations [33]. The treatment of allergic patients should not be interrupted, or dose reduction should not be made.…”
Over the recent time period, pediatric allergy clinics across the world have markedly changed their practice because of the COVID-19 pandemic. Nowadays, clinics are not inclined to accept a patient demanding a new procedure / therapeutic modality during pandemic. All allergic diseases require continuous management and treatment, and their socioeconomic burden has been increasing worldwide. In this chapter, the aim is to focus on allergic diseases management during pandemic. During this time, patient follow-up, patient management, and diagnostic tests are real challenges. Limited face-to-face consultations and as much as use of telemedicine are currently seen as the major issues in the allergy practice. Face-to-face examination and treatment should be preferred only in vital situations. During COVID-19 pandemic, patient education, which is the most important step in the treatment of allergic diseases, has started to be done online. The prevailing opinion in the allergy community is that the treatment should not be interrupted, or dose reduction should not be made. According to the guidelines, it is appropriately recommended to carefully calculate the profit and loss of the treatment on a case-by-case basis.
“…A new era of precision digital medicine is emerging in health services with the potential to revolutionize the management of CRDs patients. Telemedicine could be a significant add-on in health care, reducing inpatient and outpatient health care burden (103)(104)(105).…”
Non-transmissible chronic respiratory diseases (CRDs) are very prevalent. In this chapter, we focus on the different dimensions through which telemedicine can be delivered and used in the management of patients with chronic obstructive pulmonary disease (COPD) and asthma, the major obstructive CRDs. Telerehabilitation, health education, telemonitoring, early detection of exacerbations, psychosocial support, and smoking cessation through telemedicine programs allow the delivery of quality healthcare to COPD patients who have limited access to health services. In asthma patients, telemedicine is effective in improving inhalation technique, increasing adherence to medication/selfmanagement, and health education. We discuss the importance of virtual visits and mobile/web-based tools in the management and monitoring of patients with CRDs, the rising promise of telespirometry performed outside the hospitals, and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.